Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,141

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

March 19, 2023

Study Completion Date

November 30, 2030

Conditions
Coronary Artery Disease
Interventions
COMBINATION_PRODUCT

PCI with BioMatrix Alpha™ stent

Randomozation between either Sirolimus eluting and endothelial progenitor cell Combo™ stent or Biolimus eluting absorbable polymer coated BioMatrix Alpha™ stent

COMBINATION_PRODUCT

PCI with Combo™ stent

Randomozation between either Sirolimus eluting and endothelial progenitor cell Combo™ stent or Biolimus eluting absorbable polymer coated BioMatrix Alpha™ stent

Trial Locations (2)

5000

Odense Unversity Hospital, Odense

8200

Aarhus University Hospital, Skejby, Aarhus

Sponsors
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

OrbusNeich

INDUSTRY

collaborator

Biosensors International

OTHER

lead

Phillip Freeman

OTHER

NCT03952273 - Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent | Biotech Hunter | Biotech Hunter